Clearblue Debuts First At-Home Test To Help Women Figure Out Menopause
By Alexa Heah, 31 Aug 2023
Clearblue, creator of popular at-home pregnancy and fertility tests, is now venturing into a new territory: menopause.
Recognizing that women in or approaching menopause often lack sufficient resources and information to navigate this significant life stage, the firm is stepping up its efforts to address this gap.
Enter the Clearblue Menopause Stage Indicator, the first-ever product that combines a woman’s urine measurements with her age and cycle history to provide insights into her likely menopause stage.
With menopause not often discussed in public, a considerable portion of women, around two-thirds, feel unprepared to tackle the challenges that come with menopause.
Furthermore, only 45% of respondents believe they possess enough information to effectively manage this transition.
The Clearblue Menopause Stage Indicator operates through a dedicated application called Menopause Stage—Clearblue me. This free-to-download program serves as a secure platform to store the test results obtained from the indicator.
Results are determined based on an amalgamation of five urine tests, cycle history data, and the user’s age. By processing these inputs, the app calculates an individual’s likely menopause stage, providing one with valuable insights about their current status.
Perhaps the hidden value of this system lies in its ability to foster constructive conversations between women and their healthcare professionals.
The personalized report generated by the app can be shared during appointments, enabling a more comprehensive dialogue about menopause and the potential treatment options available.
Furthermore, the app offers symptom and cycle-tracking features, allowing women to monitor their experiences over a longer period of time.
To use the tool, users will be instructed to take five urine tests over a span of 10 days, with each test administered every other day.
Once these results, along with age and cycle history, are fed into the app, it generates a personalized report detailing the likely menopause stage, urine test outcomes, and symptoms tracked over the past six weeks.
“Clearblue has been a pioneer of innovation in the pregnancy and fertility category for over 35 years,” said Dr Fiona Clancy, PhD, R&D senior director at Clearblue.
“But we know a woman’s reproductive journey doesn’t end with trying to get or getting pregnant—the journey continues, as do her questions about what comes next. The Clearblue Menopause Stage Indicator is a game-changer that will help empower women with information and understanding of their menopause journey.”
[via Medical Device Network and SheKnows, images via Procter & Gamble]
This article was crafted with assistance from an AI engine, and has been manually reviewed & edited.